Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Column Group IV GP reports purchase of 89,200 Eikon Therapeutics shares valued at $1.03 million

Column Group IV GP reports purchase of 89,200 Eikon Therapeutics shares valued at $1.03 million

ReutersReuters2026/09/08 20:34
  • Column Group IV GP reported a purchase of 89,200 Eikon Therapeutics common shares at USD 11.56.
  • Indirect holdings reported at 4,312,139 shares via Column Group IV, 1,319,164 via Column Group Opportunity III, 148,840 via Column Group IV-A.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-385268), on September 08, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!